Clinical Laserthermia Systems
About:
Clinical Laserthermia Systems develops and markets the TRANBERG®|Thermal Therapy System for heat-induced immunotherapy.
Website: https://clinicallaser.se
Top Investors: EASME - EU Executive Agency for SMEs
Description:
Clinical Laserthermia Systems (CLS) develops and markets the TRANBERG®|Thermal Therapy System, as well as disposable materials and methods, for heat-induced immunotherapy enabling safe and gentle treatment of cancerous tumors. The products are marketed for image-guided laser ablation and for CLS’ own immunostimulating therapy, imILT®. The company is headquartered in Lund, Sweden, with subsidiaries in Berlin, Germany and in Boston, USA. CLS is listed on Nasdaq First North under the stock symbol CLS B.
2.14M EUR
$1M to $10M
Lund, Skane Lan, Sweden
2006-01-01
info(AT)clinicallaser.se
Karl Goran Tranberg, Lars-Erik T. Eriksson, Par H Henriksson
11-50
2016-08-01
Public
© 2025 bioDAO.ai